血液凝固分析装置の世界市場...市場調査レポートについてご紹介

【英文タイトル】Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 29
2.5 KEY DATA FROM SECONDARY SOURCES 29
2.6 KEY DATA FROM PRIMARY SOURCES 30
2.7 KEY INDUSTRY INSIGHTS 31
2.8 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 37
4.1 HIGH GROWTH POTENTIAL OF THE COAGULATION ANALYZERS MARKET 37
4.2 GLOBAL CLINICAL LABORATORY ANALYZERS, BY TYPE 38
4.3 GLOBAL COAGULATION ANALYZERS MARKET, BY REGION 39
4.4 COAGULATION ANALYZERS MARKET, BY INSTRUMENT 40
4.5 COAGULATION ANALYZERS MARKET, BY TEST 41
4.6 GLOBAL COAGULATION ANALYZERS MARKET, BY END USER 42
4.7 LIFECYCLE ANALYSIS, BY REGION 43

5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45

5.2 MARKET SEGMENTATION 45
5.2.1 BY PRODUCT 45
5.2.2 BY TEST 46
5.2.3 BY TECHNOLOGY 46
5.2.4 BY END USER 47
5.2.5 BY REGION 48
5.3 MARKET DYNAMICS 49
5.4 DRIVERS 50
5.4.1 INCREASING PREVALENCE OF DISEASES AND RISING NUMBER OF SURGICAL PROCEDURES 50
5.4.2 INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES 50
5.4.3 DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) COAGULATION TESTING 50
5.4.4 GROWTH IN AGING POPULATION 50
5.4.5 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 51
5.5 RESTRAINTS 53
5.5.1 SLOW ADOPTION OF ADVANCED COAGULATION INSTRUMENTS IN EMERGING ECONOMIES 53
5.5.2 HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS 53
5.6 OPPORTUNITIES 54
5.6.1 RAPID GROWTH IN THE COAGULATION MARKET IN EMERGING ECONOMIES 54
5.6.2 INCREASING NUMBER OF HEMOPHILIC PATIENTS 54
5.7 CHALLENGE 55
5.7.1 STRINGENT AND TIME-CONSUMING REGULATORY POLICIES 55

6 INDUSTRY INSIGHTS 56
6.1 INTRODUCTION 56
6.2 PORTER’S FIVE FORCES ANALYSIS 56
6.2.1 THREAT OF NEW ENTRANTS 57
6.2.2 THREAT OF SUBSTITUTES 57
6.2.3 BARGAINING POWER OF SUPPLIERS 57
6.2.4 BARGAINING POWER OF BUYERS 58
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.3 SUPPLY CHAIN ANALYSIS 59
6.3.1 KEY INFLUENCERS 60
6.4 STRATEGIC BENCHMARKING 61

7 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY TYPE OF TEST 62
7.1 INTRODUCTION 63
7.2 PROTHROMBIN TIME (PT/INR) TEST 64
7.3 ACTIVATED CLOTTING TIME (ACT/APTT) TEST 67
7.4 D-DIMER TEST 69
7.5 FIBRINOGEN TEST 71
7.6 OTHERS COAGULATION TEST 73

8 COAGULATION ANALYZERS MARKET, BY PRODUCT TYPE 76
8.1 INTRODUCTION 77
8.2 CLINICAL LABORATORY COAGULATION ANALYZERS 78
8.2.1 INSTRUMENTS 81
8.2.1.1 Fully Automated Coagulation Analyzers 85
8.2.1.2 Semi-automated and Manual Coagulation Analyzers 87
8.2.2 COAGULATION CONSUMABLES 90
8.2.2.1 Reagents 92
8.2.2.2 Standards, Controls, and Calibrators 94
8.3 POINT-OF-CARE TESTING COAGULATION ANALYZERS 97

9 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY 100
9.1 INTRODUCTION 101
9.2 PHOTO OPTICAL TECHNOLOGY 101
9.3 MECHANICAL TECHNOLOGY 102
9.4 ELECTROCHEMICAL TECHNOLOGY 102
9.5 OTHER TECHNOLOGIES 102

10 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY END USER 103
10.1 INTRODUCTION 104
10.2 RESEARCH INSTITUTES 105
10.3 DIAGNOSTIC LABORATORIES 108
10.4 STANDALONE HOSPITALS 110
10.5 OTHER END USERS 113

11 COAGULATION ANALYZERS MARKET, BY REGION 116
11.1 INTRODUCTION 117
11.2 NORTH AMERICA 121
11.2.1 U.S. 126
11.2.2 CANADA 129

11.3 EUROPE 133
11.3.1 GERMANY 136
11.3.2 FRANCE 139
11.3.3 U.K. 142
11.3.4 ITALY 145
11.3.5 SPAIN 148
11.3.6 REST OF EUROPE (ROE) 151
11.4 ASIA-PACIFIC 153
11.4.1 JAPAN 157
11.4.2 CHINA 160
11.4.3 INDIA 164
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 168
11.5 REST OF THE WORLD (ROW) 171

12 COMPETITIVE LANDSCAPE 175
12.1 OVERVIEW 175
12.2 MARKET SHARE ANALYSIS 176
12.2.1 MARKET SHARE ANALYSIS FOR CLINICAL LABORATORY ANALYZERS MARKET 176
12.2.2 MARKET SHARE ANALYSIS FOR POINT-OF-CARE COAGULATION ANALYZERS MARKET 177
12.3 COMPETITIVE SITUATION AND TRENDS 178
12.3.1 EXPANSIONS 179
12.3.2 NEW PRODUCT LAUNCHES 180
12.3.3 AGREEMENTS, PARTNERSHIPS, & ALLIANCES 181
12.3.4 ACQUISITIONS 182
12.3.5 OTHER DEVELOPMENTS 182

13 COMPANY PROFILES 183
13.1 INTRODUCTION 183
13.2 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 184
13.2.1 BUSINESS OVERVIEW 184
13.2.2 SIEMENS AG: COMPANY SNAPSHOT 184
13.2.3 PRODUCT PORTFOLIO 185
13.2.4 KEY STRATEGIES 186
13.2.5 RECENT DEVELOPMENTS 186
13.3 SYSMEX CORPORATION 188
13.3.1 BUSINESS OVERVIEW 188
13.3.2 SYSMEX CORPORATION: COMPANY SNAPSHOT 188
13.3.3 PRODUCT PORTFOLIO 189
13.3.4 KEY STRATEGIES 190
13.3.5 RECENT DEVELOPMENTS 190

13.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 191
13.4.1 BUSINESS OVERVIEW 191
13.4.2 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 191
13.4.3 PRODUCT PORTFOLIO 192
13.4.4 KEY STRATEGY 192
13.4.5 RECENT DEVELOPMENTS 192
13.5 NIHON KOHDEN CORPORATION 193
13.5.1 BUSINESS OVERVIEW 193
13.5.2 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 193
13.5.3 PRODUCT PORTFOLIO 194
13.5.4 KEY STRATEGY 194
13.5.5 RECENT DEVELOPMENTS 194
13.6 INTERNATIONAL TECHNIDYNE CORPORATION (ITC) 195
13.6.1 BUSINESS OVERVIEW 195
13.6.2 KEY FINANCIALS 195
13.6.3 PRODUCTS 195
13.6.4 KEY STRATEGY 195
13.6.5 RECENT DEVELOPMENTS 195
13.7 HELENA LABORATORIES 196
13.7.1 BUSINESS OVERVIEW 196
13.7.2 KEY FINANCIALS 196
13.7.3 PRODUCT PORTFOLIO 196
13.8 ALERE, INC. 197
13.8.1 BUSINESS OVERVIEW 197
13.8.2 ALERE, INC.: COMPANY SNAPSHOT 197
13.8.3 PRODUCT PORTFOLIO 198
13.8.4 KEY STRATEGY 198
13.9 DIAGNOSTICA STAGO SAS 199
13.9.1 BUSINESS OVERVIEW 199
13.9.2 KEY FINANCIALS 199
13.9.3 PRODUCT PORTFOLIO 199
13.9.4 KEY STRATEGY 199
13.9.5 RECENT DEVELOPMENTS 200
13.10 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 201
13.10.1 BUSINESS OVERVIEW 201
13.10.2 KEY FINANCIALS 201
13.10.3 PRODUCT PORTFOLIO 201
13.10.4 KEY STRATEGY 202
13.10.5 RECENT DEVELOPMENTS 202

13.11 THERMO FISHER SCIENTIFIC, INC. 203
13.11.1 BUSINESS OVERVIEW 203
13.11.2 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 203
13.11.3 PRODUCT PORTFOLIO 204
13.11.4 KEY STRATEGIES 204
13.11.5 RECENT DEVELOPMENTS 204

14 APPENDIX 205
14.1 INSIGHTS FROM INDUSTRY EXPERTS 205
14.2 DISCUSSION GUIDE 206
14.3 COMPANY DEVELOPMENTS (2012–2014) 209
14.3.1 SYSMEX CORPORATION 209
14.3.2 NIHON KOHEDEN CORPORATION 209
14.3.3 SIEMENS HEALTHCARE 210
14.3.4 DIAGNOSTICA STAGO, INC. 210
14.3.5 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 210
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 211
14.5 AVAILABLE CUSTOMIZATIONS 211
14.6 RELATED REPORTS 212


【レポート販売概要】

■ タイトル:血液凝固分析装置の世界市場
■ 英文:Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019
■ 発行日:2015年3月20日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD-3255
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。